Skip to main content
. Author manuscript; available in PMC: 2016 Jul 17.
Published in final edited form as: AIDS. 2015 Jul 17;29(11):1325–1333. doi: 10.1097/QAD.0000000000000654

Table 2. Factors associated with IL-6 and CRP in the 83 HCV-infected women.

All HCV-infected women

IL-6 CRP

Unadjusted Adjusted* Unadjusted Adjusted**
% difference (95%CI), p-value % difference (95%CI), p-value
Demographic Factors
Age (per decade) 16% (-34%, 101%)
p=0.61
23% (-18%, 84%)
p=0.31
37% (-27%, 126%)
p=0.22
3% (-38%, 73%)
p=0.90
Black (vs. Caucasian) 99% (-49%, 674%)
p=0.319
54% (-37%, 279%)
p=0.343
39% (-52%, 301%)
p=0.544
40% (-46%, 264%)
p=0.495
Hispanic (vs. Caucasian) 36% (-76%, 669%)
p=0.731
71% (-48%, 466%)
p=0.374
11% (-72%, 351%)
p=0.879
18% (-67%, 329%)
p=0.797
Metabolic Factors
Waist Circumference (per 10cm) 2% (-1%, 4%)
p=0.14
0% (-2%, 3%)
p=0.74
4% (2%, 6%)
p<0.0001
4% (2%, 6%)
p<0.0001
HCV-Related Factors
Liver Stiffness (per doubling) 31% (-1%, 74%)
p=0.06
34% (8%, 66%)
p=0.009
33% (4%, 70%)
p=0.02
21% (-6%, 57%)
p=0.141
HCV RNA (per doubling) -20% (-27%, -12%)
p<0.0001
-16% (-30%, 1%)
p=0.06
-7% (-26%, 3%)
p=0.17
-9% (-18%, 0%)
p=0.05
*

Outcomes are log-transformed; results are back-transformed to produce estimated relative differences in inflammatory marker attributable to each factor. Estimates are from multivariable Poisson regression models.